Zenith Health Care Ltd. shows significant underperformance across all key metrics compared to its peers in the Pharmaceuticals & Drugs sector. It has no revenue growth, earnings, or profitability metrics, making it a high-risk investment. In contrast, companies like Sun Pharmaceutical Industries Ltd. and Cipla Ltd. demonstrate strong profits, healthy growth, and reasonable valuations, marking them as sector leaders.

• • Zenith Health Care Ltd. has zero revenue growth, EPS, and profitability metrics.
• • Sun Pharmaceutical and Cipla are standout performers with strong growth, profitability, and reasonable valuation ratios.
• • Zenith's high PE ratio indicates overvaluation given its lack of performance metrics.